Earnings due: British American Tobacco BMT.DE (XETRA) 12 Feb 2026, dividend and cash flow

Q4 earnings for British American Tobacco p.l.c. (BMT.DE) are due 12 Feb 2026 and investors will watch EPS, cash flow and the dividend outlook. BMT.DE stock trades on XETRA at EUR 49.63 intraday after opening at EUR 51.00. The company reports at 16:30 CET and analyst attention centers on margin recovery and nicotine product growth. We review valuation, cash generation, and how the print could move price and yield for Germany-listed shareholders.

BMT.DE stock: Earnings preview and expectations

Analysts expect a quarter driven by stable pricing in combustible brands and growth in vapour and modern oral nicotine. BAT reports EPS of EUR 1.60 trailing twelve months and a current PE of 31.88, so investors will test whether recurring earnings justify the multiple.

Management commentary on volume trends, pricing and margins will matter. With a previous close of EUR 50.20 and intraday range EUR 49.40–51.50, a beat could push BMT.DE stock toward the year high of EUR 53.10 if guidance improves.

Recent price action, liquidity and valuation

BMT.DE stock trades with daily volume 207,066 versus an average volume of 65,251, showing above-normal activity ahead of results. Market cap on XETRA is roughly EUR 110.63 billion.

Key valuation metrics: PE ~31.88, price to book ~2.10, and price to sales ~3.77. The 50-day average is EUR 49.22 and the 200-day average is EUR 45.76, signalling medium-term support near EUR 45.76.

Meyka AI rates BMT.DE with a score out of 100

Meyka AI rates BMT.DE with a score of 72.76 out of 100 and assigns a B+ grade with a BUY suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

The proprietary score balances BAT’s strong free cash flow yield (~8.39%) and a high dividend yield (~5.46%) against leverage (debt/equity ~0.75) and a stretched PE. Grades are informational and not financial advice.

Meyka AI’s forecast model projects price trajectory

Meyka AI’s forecast model projects a yearly target of EUR 60.78 and a quarterly target of EUR 51.69. Against the current price of EUR 49.63, the 12‑month projection implies an upside of 22.49%.

Forecasts are model-based projections and not guarantees. Shorter-term monthly projection is EUR 48.68, implying slight near‑term range risk, while the three‑year target sits at EUR 86.15.

Technicals, dividend and income case

Technical indicators show neutral-to-cautious momentum: RSI 43.22, MACD negative, and ADX 33.29 indicating a defined trend. Bollinger band middle sits at EUR 48.24, underlining the current price band.

BAT yields around 5.46% on trailing dividend per share of EUR 2.43. For income investors the dividend coverage and cash flow per share (EUR 3.65 free cash flow) are key metrics to watch in the release.

Risks and opportunities ahead of the report

Risks: higher-than-expected regulatory headwinds, margin pressure from pricing changes, or weaker vapour growth could compress multiples. Net debt to EBITDA is elevated at roughly 6.34, which increases sensitivity to weaker cash flow.

Opportunities: stronger modern oral uptake, further pricing, or buybacks could lift returns. A clear operational update on margin improvement or buyback guidance could drive BMT.DE stock materially higher on XETRA.

Final Thoughts

Key takeaways for BMT.DE stock ahead of the 12 Feb 2026 earnings release: BAT enters the report with a trailing price of EUR 49.63, PE of 31.88, and a strong cash generation profile (free cash flow per share EUR 3.65). Meyka AI’s forecast model projects EUR 60.78 for the next 12 months, implying an upside of 22.49% versus today’s price; the quarterly target is EUR 51.69. The Q4 print will be a litmus test for management’s ability to convert vapour and modern oral growth into margin expansion. Income investors should weigh the 5.46% yield against leverage (debt/equity 0.75) and payout coverage. Use the report to re-assess exposure: a clean beat plus constructive guidance supports the Meyka B+ view, while weak guidance may widen downside to short-term support near the 200-day average of EUR 45.76. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.